» Articles » PMID: 22903242

Establishing Baseline Rod Electroretinogram Values in Achromatopsia and Cone Dystrophy

Overview
Journal Doc Ophthalmol
Specialty Ophthalmology
Date 2012 Aug 21
PMID 22903242
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To establish the normal range of values for rod-isolated b-wave amplitudes in achromatopsia and cone dystrophies.

Methods: We reviewed charts of 112 patients with various types of cone dystrophy, and compared their standardized electroretinographic rod b-wave amplitudes with age-matched normal controls. Twenty-six patients had known mutations in achromatopsia and cone dystrophy genes, while 53 were characterized by their inheritance pattern since they had yet to have their gene identified. Visual acuity information and scotomata were documented.

Results: We found that patients with achromatopsia and cone dystrophy had rod b-wave amplitudes that were significantly lower than age-matched controls, but found no evidence of rod amplitude progression nor loss of peripheral visual fields in the study group.

Conclusions: We found that cone dystrophy patients of all types had depressed rod-isolated ERGs across the board. If typical diagnostic criteria are used, these patients might be considered to have "abnormal" rod-isolated electroretinographic values, and might be called "cone-rod dystrophy", even though the waveforms are stable for years. Patients with cone-rod dysfunction patterns on ERG can be better understood by also performing kinetic (Goldmann) visual fields, which will help to distinguish cone dystrophies from progressive cone-rod dystrophies by central scotomata size and progression over time in many forms of cone-rod dystrophy.

Citing Articles

Application of Electrophysiology in Non-Macular Inherited Retinal Dystrophies.

Haraguchi Y, Chiang T, Yu M J Clin Med. 2023; 12(21).

PMID: 37959417 PMC: 10649281. DOI: 10.3390/jcm12216953.


Differences in ocular findings in two siblings: one with complete and other with incomplete achromatopsia.

Ueno S, Nakanishi A, Sayo A, Kominami T, Ito Y, Hayashi T Doc Ophthalmol. 2017; 134(2):141-147.

PMID: 28197754 DOI: 10.1007/s10633-017-9577-y.


The morphology of human rod ERGs obtained by silent substitution stimulation.

Maguire J, Parry N, Kremers J, Murray I, McKeefry D Doc Ophthalmol. 2017; 134(1):11-24.

PMID: 28091887 PMC: 5274650. DOI: 10.1007/s10633-017-9571-4.


Disease progression in autosomal dominant cone-rod dystrophy caused by a novel mutation (D100G) in the GUCA1A gene.

Nong E, Lee W, Merriam J, Allikmets R, Tsang S Doc Ophthalmol. 2013; 128(1):59-67.

PMID: 24352742 PMC: 3974164. DOI: 10.1007/s10633-013-9420-z.

References
1.
Johnson S, Michaelides M, Aligianis I, Ainsworth J, Mollon J, Maher E . Achromatopsia caused by novel mutations in both CNGA3 and CNGB3. J Med Genet. 2004; 41(2):e20. PMC: 1735666. DOI: 10.1136/jmg.2003.011437. View

2.
Khan N, Wissinger B, Kohl S, Sieving P . CNGB3 achromatopsia with progressive loss of residual cone function and impaired rod-mediated function. Invest Ophthalmol Vis Sci. 2007; 48(8):3864-71. DOI: 10.1167/iovs.06-1521. View

3.
Thiagalingam S, McGee T, Weleber R, Sandberg M, Trzupek K, Berson E . Novel mutations in the KCNV2 gene in patients with cone dystrophy and a supernormal rod electroretinogram. Ophthalmic Genet. 2007; 28(3):135-42. DOI: 10.1080/13816810701503681. View

4.
Xu J, Morris L, Michalakis S, Biel M, Fliesler S, Sherry D . CNGA3 deficiency affects cone synaptic terminal structure and function and leads to secondary rod dysfunction and degeneration. Invest Ophthalmol Vis Sci. 2012; 53(3):1117-29. PMC: 3339899. DOI: 10.1167/iovs.11-8168. View

5.
Wu H, Cowing J, Michaelides M, Wilkie S, Jeffery G, Jenkins S . Mutations in the gene KCNV2 encoding a voltage-gated potassium channel subunit cause "cone dystrophy with supernormal rod electroretinogram" in humans. Am J Hum Genet. 2006; 79(3):574-9. PMC: 1559534. DOI: 10.1086/507568. View